Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

stifel-resumes-dexcom-stock-coverage-with-buy-rating-on-15-day-sensor-potential-by-investing.com

Stifel resumes DexCom stock coverage with Buy rating on 15-day sensor potential By Investing.com

Oct 21, 2025

Stifel resumes DexCom stock coverage with Buy rating on 15-day sensor potential

Read more
research-reports-&-trade-ideas

Research Reports & Trade Ideas

Oct 21, 2025

Skip to navigation Skip to main content Skip to right column All / Analyst Report Argus • Oct…

Read more
emerging-growth-research-initiates-coverage-on-osr-holdings,-inc-with-a-buy-emerging-rating-and-$10.00-price-target

Emerging Growth Research Initiates Coverage on OSR Holdings, Inc. with a Buy-Emerging Rating and $10.00 Price Target

Oct 20, 2025

October 20, 2025 11:40 AM EDT | Source: Emerging Growth Research New York, New York–(Newsfile Corp. – October…

Read more
canadian-analyst-coverage-updates:-oct-20th,-2025

Canadian Analyst Coverage Updates: Oct 20th, 2025

Oct 20, 2025

Analyst Ratings (Canada) The following are today’s latest 96 analyst ratings tracked from muliple analysts for Canadian listed…

Read more
getty-realty-(gty):-exploring-valuation-following-fresh-analyst-coverage-and-renewed-investor-interest

Getty Realty (GTY): Exploring Valuation Following Fresh Analyst Coverage and Renewed Investor Interest

Oct 20, 2025

Investor interest in Getty Realty (GTY) has picked up after a well-known research firm initiated coverage. The firm…

Read more
will-analyst-coverage-and-promising-data-shift-wave-life-sciences’-(wve)-genetic-medicine-narrative?

Will Analyst Coverage and Promising Data Shift Wave Life Sciences’ (WVE) Genetic Medicine Narrative?

Oct 20, 2025

Clear Street recently initiated coverage of Wave Life Sciences, highlighting the company’s pipeline of genetic medicines, including WVE-007…

Read more
stifel-resumes-tandem-diabetes-care-stock-coverage-with-hold-rating-by-investing.com

Stifel resumes Tandem Diabetes Care stock coverage with Hold rating By Investing.com

Oct 20, 2025

Stifel resumes Tandem Diabetes Care stock coverage with Hold rating

Read more
usa-rare-earth-is-skyrocketing-today-—-is-the-stock-a-buy-right-now?

USA Rare Earth Is Skyrocketing Today — Is the Stock a Buy Right Now?

Oct 20, 2025

Motley Fool – Mon Oct 20, 2:44PM CDT Key Points USA Rare Earth stock is rising today thanks…

Read more
canadian-analyst-coverage-updates:-oct-20th,-2025

Canadian Analyst Coverage Updates: Oct 20th, 2025

Oct 20, 2025

Analyst Ratings (Canada) The following are today’s latest 96 analyst ratings tracked from muliple analysts for Canadian listed…

Read more
upstream-bio-(upb):-fresh-data-and-analyst-coverage-spark-new-questions-on-valuation

Upstream Bio (UPB): Fresh Data and Analyst Coverage Spark New Questions on Valuation

Oct 20, 2025

Upstream Bio (UPB) recently made headlines after presenting fresh structural and mechanistic insights for its promising drug candidate,…

Read more
digital-realty-(dlr):-evaluating-valuation-following-new-analyst-coverage-and-enterprise-ai-partnership-announcements

Digital Realty (DLR): Evaluating Valuation Following New Analyst Coverage and Enterprise AI Partnership Announcements

Oct 20, 2025

Digital Realty Trust (DLR) has drawn new attention after Morgan Stanley initiated coverage and the company announced fresh…

Read more
usa-rare-earth-is-skyrocketing-today-—-is-the-stock-a-buy-right-now?

USA Rare Earth Is Skyrocketing Today — Is the Stock a Buy Right Now?

Oct 20, 2025

Key Points USA Rare Earth stock is rising today thanks to positive momentum for the broader market and…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 181
  6. 182
  7. 183
  8. 184
  9. 185
  10. 186
  11. 187
  12. ...
  13. 451
  14. »

Posts pagination

Newer posts Page 1 … Page 184 … Page 451 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.